跳轉至內容
Merck
全部照片(3)

Key Documents

View All Documentation

228435

Sigma-Aldrich

5-溴吡啶-3-羧酸

98%

同義詞:

5-溴烟酸

登入查看組織和合約定價
全部照片(3)

About This Item

經驗公式（希爾表示法）:
C6H4BrNO2
CAS號碼:
20826-04-4
分子量：:
202.01
Beilstein:
115854
EC號碼:
244-065-5
MDL號碼:
MFCD00009783
分類程式碼代碼:
12352100
PubChem物質ID:
24853685
NACRES:
NA.22

品質等級

100

化驗

98%

形狀

solid

mp

178-180 °C (lit.)

官能基

bromo
carboxylic acid

SMILES 字串

OC(=O)c1cncc(Br)c1

InChI

1S/C6H4BrNO2/c7-5-1-4(6(9)10)2-8-3-5/h1-3H,(H,9,10)

InChI 密鑰

FQIUCPGDKPXSLL-UHFFFAOYSA-N

尋找類似的產品？ 前往 產品比較指南

相關類別

應用

5-溴吡啶-3-羧酸（5-溴烟酸）用于合成3-胍基甲基-5-碘吡啶。

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves

從最近期的版本中選擇一個：

分析證明 (COA)

Lot/Batch Number
STBJ8674
STBJ4180
STBJ4181
STBG9188
S22745V

未看到正確版本？

如果您需要一個特定的版本，您可以透過批號來尋找特定憑證。

搜尋 COA

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

G Vaidyanathan et al.
Bioconjugate chemistry, 9(6), 758-764 (1998-11-17)
Substituting a pyridine ring for a benzene ring in the acylation agent N-succinimidyl 3-iodobenzoate has resulted in a useful approach for the radiohalogenation of monoclonal antibodies, peptides, and labeled biotin conjugates. It was hypothesized that such a substitution in m-iodobenzylguanidine
Małgorzata Dukat et al.
European journal of pharmacology, 435(2-3), 171-180 (2002-02-01)
Two 5-substituted derivatives of nicotine (nicotinic acetylcholine receptor: K(i)=2.4 nM) were synthesized and evaluated: 5-bromonicotine (K(i)=6.9 nM) and 5-methoxynicotine (K(i)=14.3 nM). Despite their high affinity, neither 5-bromonicotine nor 5-methoxynicotine mimicked nicotine in producing antinociceptive (tail-flick, hotplate), hypolocomotor, or hypothermic effects
F Gabor et al.
Journal of pharmaceutical sciences, 84(9), 1120-1125 (1995-09-01)
Two types of monoclonal antibodies were used for the determination of nicergoline in biological matrices. The antibodies were prepared with the hydrolysis products 5-bromonicotinic acid and 1-methyl-10 alpha-methoxydihydrolysergol after hemisuccinoylation to haptens. The current amide bond-generating methods (mixed anhydride-, carbodiimide-
Tawfik Gharbaoui et al.
Bioorganic & medicinal chemistry letters, 17(17), 4914-4919 (2007-06-26)
A strategy for lead identification of new agonists of GPR109a, starting from known compounds shown to activate the receptor, is described. Early compound triage led to the formulation of a binding hypothesis and eventually to our focus on a series

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務